Literature DB >> 7522834

A study of anti-hepatitis C positive blood donors: the first year of screening.

S MacLennan1, M C Moore, P E Hewitt, S Nicholas, J A Barbara.   

Abstract

In the U.K., blood donations have been routinely screened for anti-HCV since September 1991. In order to get the most epidemiological benefit from these extensive screening data, the histories obtained at counselling from donors confirmed to be anti-HCV positive, 'indeterminate' and falsely positive have been analysed in detail. In addition, the associations with potential risk factors have been investigated by comparing these groups of donors with a control group of 771 routine donors bled on one day during the study, at North London Blood Transfusion Centre. This paper documents the prevalence and demography of HCV infection in asymptomatic blood donors, to assess various possible sources of infection and the association between liver function test results and alcohol consumption in donors. One in 1400 previously untested donors was confirmed positive for anti-HCV. Age (the group 30-49 years being highest), tattooing and intravenous drug use in both sexes, ear-piercing in males and blood transfusion in females were all significantly associated with an increased risk of HCV infection. Intravenous drug use proved to be the factor most strongly associated with risk. Liver function tests (alanine aminotransferase) were elevated in a significant number of donors confirmed to be anti-HCV positive but no clear correlation between alanine aminotransferase level and either time since infection or alcohol consumption was found. Alcohol consumption was significantly higher in donors confirmed to be anti-HCV positive and was particularly marked in those admitting to previous intravenous drug use.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522834     DOI: 10.1111/j.1365-3148.1994.tb00253.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  9 in total

1.  The risks of infection transmission by blood transfusion in England.

Authors:  K Soldan; J Barbara
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

Review 2.  Body piercing medical concerns with cutting-edge fashion.

Authors:  L M Koenig; M Carnes
Journal:  J Gen Intern Med       Date:  1999-06       Impact factor: 5.128

3.  Risk of hepatitis C virus infection from tattooing and other skin piercing services.

Authors:  G H Shimokura; P R Gully
Journal:  Can J Infect Dis       Date:  1995-09

4.  Hepatitis C virus risk factors in the Turkish community.

Authors:  Beytullah Yildirim; Veysel Tahan; Resat Ozaras; Huseyin Aytekin; Ali Mert; Fehmi Tabak; Hakan Senturk
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

5.  Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5.

Authors:  K Soldan; J A Barbara; J Heptonstall
Journal:  BMJ       Date:  1998-05-09

Review 6.  Sexual transmission of hepatitis C virus infection.

Authors:  G Rooney; R J Gilson
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

7.  Risk factors for hepatitis C virus infection among street youths.

Authors:  E Roy; N Haley; P Leclerc; J F Boivin; L Cédras; J Vincelette
Journal:  CMAJ       Date:  2001-09-04       Impact factor: 8.262

8.  Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.

Authors:  Sérgio A de Nishioka; T W Gyorkos; L Joseph; J P Collet; J D MacLean
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 9.  Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis.

Authors:  Shigui Yang; Dan Wang; Yuelun Zhang; Chengbo Yu; Jingjing Ren; Kaijin Xu; Min Deng; Guo Tian; Cheng Ding; Qing Cao; Yiping Li; Ping Chen; Tiansheng Xie; Chencheng Wang; Bing Wang; Jun Yao; Diane Threapleton; Chen Mao; Bing Ruan; Lanjuan Li
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.